FDA Inspection
Actavis Elizabeth LLC, A Company of TevaActavis Elizabeth LLC, A Company of Teva – FDA Inspection, Feb 15, 2013
Record Details
This FDA Inspection record concerns Actavis Elizabeth LLC, A Company of Teva, with an inspection on February 15, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 15, 2013
- Product Type
- Drugs
View Company Profile
ID · 3db13e96-37ea-4cfa-ab24-dca12b6d4806
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 817987
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Actavis Elizabeth LLC, A Company of Teva
14| Date | Classification | Office | Project area |
|---|---|---|---|
| July 24, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 19, 2017 | Not classified | New Jersey District Office | |
| February 15, 2017 | NAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| December 5, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Actavis Elizabeth LLC, A Company of Teva
- FDA Inspection 1215838 - 2023-07-24
- FDA Inspection 1041770 - 2018-02-05
- FDA Inspection 1017122 - 2017-05-19
- FDA Inspection 1003801 - 2017-02-15
- FDA Inspection 994679 - 2016-12-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.